Smart Money · Holder IQ
Above median holder quality (percentile 59.3 this quarter).
Reading stored signals…
Healthcare • Biotechnology
Per-share book value with reinvested dividends, and the steadiness of its 40-quarter trend.
As of · Window to
Historical book-value growth with dividends
· 100 indexed · 0.2 per share
· 92.2 indexed · 0.2 per share
· 82.3 indexed · 0.2 per share
· 74.5 indexed · 0.2 per share
· 922 indexed · 2.3 per share
· 1,057.6 indexed · 2.6 per share
· 1,042.5 indexed · 2.6 per share
· 886.1 indexed · 2.2 per share
· 815 indexed · 2 per share
· 691.9 indexed · 1.7 per share
· 546.3 indexed · 1.4 per share
· 450.3 indexed · 1.1 per share
· 391.8 indexed · 1 per share
· 338.9 indexed · 0.8 per share
· 271.6 indexed · 0.7 per share
· 237.1 indexed · 0.6 per share
· 249.6 indexed · 0.6 per share
· 243.7 indexed · 0.6 per share
· 182.4 indexed · 0.5 per share
· 373.7 indexed · 0.9 per share
· 376.6 indexed · 0.9 per share
· 364.2 indexed · 0.9 per share
· 341.4 indexed · 0.8 per share
· 323.7 indexed · 0.8 per share
· 302 indexed · 0.8 per share
· 282.8 indexed · 0.7 per share
· 276.3 indexed · 0.7 per share
· 250.6 indexed · 0.6 per share
· 247.4 indexed · 0.6 per share
· 230 indexed · 0.6 per share
· 214.4 indexed · 0.5 per share
· 200.6 indexed · 0.5 per share
· 190.7 indexed · 0.5 per share
· 3,889 indexed · 9.7 per share
· 3,404.4 indexed · 8.5 per share
· 2,784.8 indexed · 6.9 per share
· 1,807.6 indexed · 4.5 per share
· 1,503.7 indexed · 3.7 per share
· 1,437.1 indexed · 3.6 per share
· 1,106.1 indexed · 2.8 per share
· 975.9 indexed · 2.4 per share
Basis: total common book, used as the fallback basis for the whole window. Dividends are reinvested at book value.
No decline detected by the published slope-ratio test.
The compounder rule requires a top-decile composite, positive slope and no detected decline in the tangible-book eligible pool. Total-common-book fallback rows cannot qualify. Decline means the 90% interval for recent / whole-window slope lies below 1.
Source: SEC first-filed XBRL. Midas Edge API’s published Green Compounders method uses only filings public by the as-of date, split-adjusted shares and the original filed values. Restatements do not replace them. Issuer pools and entity types reflect the SEC submissions captured for this run, not historical classifications at each as-of date.
The primary form fits log book value with reinvested dividends against time. The method checks the starting book and market-cap floors and excludes identified non-reliance/enforcement windows. Its cohort is fixed at capture time, so historical percentiles have capture and survival limits. It does not check audit-opinion going-concern text. This grade is separate from InsiderIQ, HolderIQ and NetCredibility.
Input filings (42 in this window): 0001213900-17-013191; 0001213900-18-001880; 0001213900-18-005952. The links show up to three of the input filings.
Method notes: An additional method qualification is recorded in the publication receipt. An additional method qualification is recorded in the publication receipt. An additional method qualification is recorded in the publication receipt. Going-concern audit wording was not evaluated. An additional method qualification is recorded in the publication receipt. Missing dividend facts were treated as zero by the published method. No preferred-equity fact was filed; the method used zero. Enforcement findings use records naming the issuer. The history contains a large unexplained tangible-book decline.
Trailing twelve-month statements · as of Nov 13, 2026 · multiples on the Nov 12, 2026 market cap
End-of-day close from stored market data, not a live quote.
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma.
The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Company profile stored Nov 2, 2026.
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 14, 2026 | $1.5M | — | -48.1% | -$11.7M | -$8.9M |
| Mar 2026filed May 15, 2026 | $1.7M | — | -22.9% | -$32.2M | -$21.2M |
| Dec 2025filed Feb 13, 2026 | $3.9M | +2,429.5% | 65.5% | -$9.0M | -$8.2M |
| Sep 2025filed Dec 23, 2025 | — | — | — | -$8.4M | -$8.0M |
| Jun 2025filed Aug 12, 2025 | — | — | — | -$8.8M | -$8.8M |
| Mar 2025filed May 14, 2025 | — | — | — | -$11.3M | -$10.9M |
| Dec 2024filed Feb 14, 2025 | $155.9K | — | — | -$10.0M | -$9.8M |
| Sep 2024filed Dec 27, 2024 | $155.9K | — | — | -$11.1M | -$10.8M |
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2025filed Dec 23, 2025 | — | — | — | -$38.5M | -$37.4M |
| Sep 2024filed Dec 27, 2024 | — | — | — | -$42.0M | -$39.1M |
| Sep 2023filed Dec 29, 2023 | — | — | — | -$36.7M | -$32.5M |
| Sep 2022filed Dec 22, 2022 | — | — | — | -$33.3M | -$33.6M |
| Sep 2021filed Dec 15, 2021 | — | — | — | -$23.5M | -$23.1M |
| Sep 2020filed Dec 16, 2020 | — | — | — | -$17.7M | -$17.5M |
Does profit turn into cash? Compare CTXR’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
Fiscal year ending
Fiscal year ending
Fiscal year ending
Fiscal year ending
Fiscal year ending
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Where did CTXR’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement Oct 30, 2026
5,764,914 shares short
+66,829 shares (+1.2%) vs Oct 15, 2026
21.4% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
5,698,085 shares short
+109,088 shares (+2%) vs Sep 30, 2026
21.1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
5,588,997 shares short
+27,907 shares (+0.5%) vs Sep 15, 2026
20.7% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
5,561,090 shares short
-70,477 shares (-1.3%) vs Aug 31, 2026
20.6% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
5,631,567 shares short
+264,638 shares (+4.9%) vs Aug 14, 2026
Published Sep 10, 2026.
Settlement Aug 14, 2026
5,366,929 shares short
+208,885 shares (+4%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
5,158,044 shares short
+176,375 shares (+3.5%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
4,981,669 shares short
+217,882 shares (+4.6%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
4,763,787 shares short
-119,764 shares (-2.5%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
4,883,551 shares short
-64,772 shares (-1.3%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
4,948,323 shares short
-215,200 shares (-4.2%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
5,163,523 shares short
-100,009 shares (-1.9%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
5,263,532 shares short
+1,258,958 shares (+31.4%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
4,004,574 shares short
+99,380 shares (+2.5%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
3,905,194 shares short
-139,744 shares (-3.5%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
4,044,938 shares short
+702,990 shares (+21%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
3,341,948 shares short
+213,929 shares (+6.8%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
3,128,019 shares short
+408,375 shares (+15%) vs Jan 30, 2026
Published Feb 25, 2026.
Settlement Jan 30, 2026
2,719,644 shares short
-202,898 shares (-6.9%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
2,922,542 shares short
-244,276 shares (-7.7%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
3,166,818 shares short
+538,717 shares (+20.5%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
2,628,101 shares short
+229,653 shares (+9.6%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
2,398,448 shares short
+58,654 shares (+2.5%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
2,339,794 shares short
-240,994 shares (-9.3%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
2,580,788 shares short
+998,829 shares (+63.1%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
1,581,959 shares short
+603,134 shares (+61.6%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
978,825 shares short
-55,043 shares (-5.3%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
1,033,868 shares short
+238,550 shares (+30%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
795,318 shares short
+136,773 shares (+20.8%) vs Aug 15, 2025
Published Sep 10, 2025.
Settlement Aug 15, 2025
658,545 shares short
-110,774 shares (-14.4%) vs Jul 31, 2025
Published Aug 26, 2025.
Settlement Jul 31, 2025
769,319 shares short
-352,567 shares (-31.4%) vs Jul 15, 2025
Published Aug 11, 2025.
Settlement Jul 15, 2025
1,121,886 shares short
+152,200 shares (+15.7%) vs Jun 30, 2025
Published Jul 24, 2025.
Settlement Jun 30, 2025
969,686 shares short
-378,734 shares (-28.1%) vs Jun 13, 2025
Published Jul 10, 2025.
Settlement Jun 13, 2025
1,348,420 shares short
+683,805 shares (+102.9%) vs May 30, 2025
Published Jun 25, 2025.
Settlement May 30, 2025
664,615 shares short
+61,203 shares (+10.1%) vs May 15, 2025
Published Jun 10, 2025.
Settlement May 15, 2025
603,412 shares short
-67,146 shares (-10%) vs Apr 30, 2025
Published May 27, 2025.
Settlement Apr 30, 2025
670,558 shares short
-85,352 shares (-11.3%) vs Apr 15, 2025
Published May 9, 2025.
Settlement Apr 15, 2025
755,910 shares short
+74,670 shares (+11%) vs Mar 31, 2025
Published Apr 25, 2025.
Settlement Mar 31, 2025
681,240 shares short
+163,654 shares (+31.6%) vs Mar 14, 2025
Published Apr 9, 2025.
Settlement Mar 14, 2025
517,586 shares short
-29,428 shares (-5.4%) vs Feb 28, 2025
Published Mar 25, 2025.
Settlement Feb 28, 2025
547,014 shares short
+6,875 shares (+1.3%) vs Feb 14, 2025
Published Mar 11, 2025.
Settlement Feb 14, 2025
540,139 shares short
+26,243 shares (+5.1%) vs Jan 31, 2025
Published Feb 26, 2025.
Settlement Jan 31, 2025
513,896 shares short
-73,113 shares (-12.5%) vs Jan 15, 2025
Published Feb 11, 2025.
Settlement Jan 15, 2025
587,009 shares short
-8,324 shares (-1.4%) vs Dec 31, 2024
Published Jan 27, 2025.
Settlement Dec 31, 2024
595,333 shares short
+71,465 shares (+13.6%) vs Dec 13, 2024
Published Jan 10, 2025.
Settlement Dec 13, 2024
523,868 shares short
-79,874 shares (-13.2%) vs Nov 29, 2024
Published Dec 24, 2024.
Settlement Nov 29, 2024
603,742 shares short
Published Dec 10, 2024.
Settlement Nov 15, 2024
13,446,411 shares short
+1,658,776 shares (+14.1%) vs Oct 31, 2024
Published Nov 26, 2024.
Settlement Oct 31, 2024
11,787,635 shares short
-634,328 shares (-5.1%) vs Oct 15, 2024
Published Nov 11, 2024.
Settlement Oct 15, 2024
12,421,963 shares short
-346,400 shares (-2.7%) vs Sep 30, 2024
Published Oct 24, 2024.
Settlement Sep 30, 2024
12,768,363 shares short
+237,767 shares (+1.9%) vs Sep 13, 2024
Published Oct 9, 2024.
Settlement Sep 13, 2024
12,530,596 shares short
-858,568 shares (-6.4%) vs Aug 30, 2024
Published Sep 24, 2024.
Settlement Aug 30, 2024
13,389,164 shares short
+1,105,689 shares (+9%) vs Aug 15, 2024
Published Sep 11, 2024.
Settlement Aug 15, 2024
12,283,475 shares short
-2,342,483 shares (-16%) vs Jul 31, 2024
Published Aug 26, 2024.
Settlement Jul 31, 2024
14,625,958 shares short
+2,621,291 shares (+21.8%) vs Jul 15, 2024
Published Aug 9, 2024.
Settlement Jul 15, 2024
12,004,667 shares short
-2,149,860 shares (-15.2%) vs Jun 28, 2024
Published Jul 24, 2024.
Settlement Jun 28, 2024
14,154,527 shares short
-1,308,709 shares (-8.5%) vs Jun 14, 2024
Published Jul 10, 2024.
Settlement Jun 14, 2024
15,463,236 shares short
-442,517 shares (-2.8%) vs May 31, 2024
Published Jun 26, 2024.
Settlement May 31, 2024
15,905,753 shares short
+1,424,442 shares (+9.8%) vs May 15, 2024
Published Jun 11, 2024.
Settlement May 15, 2024
14,481,311 shares short
+53,079 shares (+0.4%) vs Apr 30, 2024
Published May 24, 2024.
Settlement Apr 30, 2024
14,428,232 shares short
+1,233,601 shares (+9.3%) vs Apr 15, 2024
Published May 9, 2024.
Settlement Apr 15, 2024
13,194,631 shares short
+769,162 shares (+6.2%) vs Mar 28, 2024
Published Apr 24, 2024.
Settlement Mar 28, 2024
12,425,469 shares short
+245,206 shares (+2%) vs Mar 15, 2024
Published Apr 9, 2024.
Settlement Mar 15, 2024
12,180,263 shares short
+316,811 shares (+2.7%) vs Feb 29, 2024
Published Mar 26, 2024.
Settlement Feb 29, 2024
11,863,452 shares short
+282,173 shares (+2.4%) vs Feb 15, 2024
Published Mar 11, 2024.
Settlement Feb 15, 2024
11,581,279 shares short
-32,377 shares (-0.3%) vs Jan 31, 2024
Published Feb 27, 2024.
Settlement Jan 31, 2024
11,613,656 shares short
-2,323,018 shares (-16.7%) vs Jan 12, 2024
Published Feb 9, 2024.
Settlement Jan 12, 2024
13,936,674 shares short
-681,509 shares (-4.7%) vs Dec 29, 2023
Published Jan 24, 2024.
Settlement Dec 29, 2023
14,618,183 shares short
+1,156,881 shares (+8.6%) vs Dec 15, 2023
Published Jan 10, 2024.
Settlement Dec 15, 2023
13,461,302 shares short
-2,369,896 shares (-15%) vs Nov 30, 2023
Published Dec 26, 2023.
Settlement Nov 30, 2023
15,831,198 shares short
-193,966 shares (-1.2%) vs Nov 15, 2023
Published Dec 11, 2023.
Settlement Nov 15, 2023
16,025,164 shares short
-864,518 shares (-5.1%) vs Oct 31, 2023
Published Nov 24, 2023.
Settlement Oct 31, 2023
16,889,682 shares short
-318,375 shares (-1.9%) vs Oct 13, 2023
Published Nov 9, 2023.
Settlement Oct 13, 2023
17,208,057 shares short
-1,328,754 shares (-7.2%) vs Sep 29, 2023
Published Oct 24, 2023.
Settlement Sep 29, 2023
18,536,811 shares short
-881,766 shares (-4.5%) vs Sep 15, 2023
Published Oct 10, 2023.
Settlement Sep 15, 2023
19,418,577 shares short
-217,952 shares (-1.1%) vs Aug 31, 2023
Published Sep 26, 2023.
Settlement Aug 31, 2023
19,636,529 shares short
-215,111 shares (-1.1%) vs Aug 15, 2023
Published Sep 11, 2023.
Settlement Aug 15, 2023
19,851,640 shares short
-944,056 shares (-4.5%) vs Jul 31, 2023
Published Aug 24, 2023.
Settlement Jul 31, 2023
20,795,696 shares short
+406,354 shares (+2%) vs Jul 14, 2023
Published Aug 9, 2023.
Settlement Jul 14, 2023
20,389,342 shares short
+1,629,168 shares (+8.7%) vs Jun 30, 2023
Published Jul 25, 2023.
Settlement Jun 30, 2023
18,760,174 shares short
+4,089,852 shares (+27.9%) vs Jun 15, 2023
Published Jul 11, 2023.
Settlement Jun 15, 2023
14,670,322 shares short
+913,420 shares (+6.6%) vs May 31, 2023
Published Jun 26, 2023.
Settlement May 31, 2023
13,756,902 shares short
+1,628,432 shares (+13.4%) vs May 15, 2023
Published Jun 9, 2023.
Settlement May 15, 2023
12,128,470 shares short
-1,471,805 shares (-10.8%) vs Apr 28, 2023
Published May 24, 2023.
Settlement Apr 28, 2023
13,600,275 shares short
+853,416 shares (+6.7%) vs Apr 14, 2023
Published May 9, 2023.
Settlement Apr 14, 2023
12,746,859 shares short
+772,630 shares (+6.5%) vs Mar 31, 2023
Published Apr 25, 2023.
Settlement Mar 31, 2023
11,974,229 shares short
+523,234 shares (+4.6%) vs Mar 15, 2023
Published Apr 11, 2023.
Settlement Mar 15, 2023
11,450,995 shares short
+170,242 shares (+1.5%) vs Feb 28, 2023
Published Mar 24, 2023.
Settlement Feb 28, 2023
11,280,753 shares short
+309,347 shares (+2.8%) vs Feb 15, 2023
Published Mar 9, 2023.
Settlement Feb 15, 2023
10,971,406 shares short
-629,365 shares (-5.4%) vs Jan 31, 2023
Published Feb 24, 2023.
Settlement Jan 31, 2023
11,600,771 shares short
+720,627 shares (+6.6%) vs Jan 13, 2023
Published Feb 9, 2023.
Settlement Jan 13, 2023
10,880,144 shares short
-78,987 shares (-0.7%) vs Dec 30, 2022
Published Jan 24, 2023.
Settlement Dec 30, 2022
10,959,131 shares short
-378,233 shares (-3.3%) vs Dec 15, 2022
Published Jan 10, 2023.
Settlement Dec 15, 2022
11,337,364 shares short
-56,386 shares (-0.5%) vs Nov 30, 2022
Published Dec 26, 2022.
Settlement Nov 30, 2022
11,393,750 shares short
+493,442 shares (+4.5%) vs Nov 15, 2022
Published Dec 9, 2022.
Settlement Nov 15, 2022
10,900,308 shares short
+138,123 shares (+1.3%) vs Oct 31, 2022
Published Nov 24, 2022.
Settlement Oct 31, 2022
10,762,185 shares short
-325,618 shares (-2.9%) vs Oct 14, 2022
Published Nov 9, 2022.
Settlement Oct 14, 2022
11,087,803 shares short
-16,904 shares (-0.2%) vs Sep 30, 2022
Published Oct 25, 2022.
Settlement Sep 30, 2022
11,104,707 shares short
+665,497 shares (+6.4%) vs Sep 15, 2022
Published Oct 11, 2022.
Settlement Sep 15, 2022
10,439,210 shares short
+360,827 shares (+3.6%) vs Aug 31, 2022
Published Sep 26, 2022.
Settlement Aug 31, 2022
10,078,383 shares short
+198,157 shares (+2%) vs Aug 15, 2022
Published Sep 9, 2022.
Settlement Aug 15, 2022
9,880,226 shares short
-69,636 shares (-0.7%) vs Jul 29, 2022
Published Aug 24, 2022.
Settlement Jul 29, 2022
9,949,862 shares short
-503,520 shares (-4.8%) vs Jul 15, 2022
Published Aug 9, 2022.
Settlement Jul 15, 2022
10,453,382 shares short
+108,387 shares (+1%) vs Jun 30, 2022
Published Jul 26, 2022.
Settlement Jun 30, 2022
10,344,995 shares short
-4,248,772 shares (-29.1%) vs Jun 15, 2022
Published Jul 11, 2022.
Settlement Jun 15, 2022
14,593,767 shares short
-397,263 shares (-2.7%) vs May 31, 2022
Published Jun 24, 2022.
Settlement May 31, 2022
14,991,030 shares short
+997,398 shares (+7.1%) vs May 13, 2022
Published Jun 9, 2022.
Settlement May 13, 2022
13,993,632 shares short
+759,707 shares (+5.7%) vs Apr 29, 2022
Published May 24, 2022.
Settlement Apr 29, 2022
13,233,925 shares short
+3,919,873 shares (+42.1%) vs Mar 31, 2022
Published May 10, 2022.
Settlement Mar 31, 2022
9,314,052 shares short
+226,372 shares (+2.5%) vs Mar 15, 2022
Published Apr 11, 2022.
Settlement Mar 15, 2022
9,087,680 shares short
+155,306 shares (+1.7%) vs Feb 28, 2022
Published Mar 24, 2022.
Settlement Feb 28, 2022
8,932,374 shares short
-1,129,625 shares (-11.2%) vs Feb 15, 2022
Published Mar 9, 2022.
Settlement Feb 15, 2022
10,061,999 shares short
-652,614 shares (-6.1%) vs Jan 31, 2022
Published Feb 24, 2022.
Settlement Jan 31, 2022
10,714,613 shares short
-596,472 shares (-5.3%) vs Jan 14, 2022
Published Feb 9, 2022.
Settlement Jan 14, 2022
11,311,085 shares short
-845,834 shares (-7%) vs Dec 31, 2021
Published Jan 25, 2022.
Settlement Dec 31, 2021
12,156,919 shares short
-950,716 shares (-7.3%) vs Dec 15, 2021
Published Jan 11, 2022.
Settlement Dec 15, 2021
13,107,635 shares short
+316,059 shares (+2.5%) vs Nov 30, 2021
Published Dec 24, 2021.
Settlement Nov 30, 2021
12,791,576 shares short
-666,002 shares (-4.9%) vs Nov 15, 2021
Published Dec 9, 2021.
Settlement Nov 15, 2021
13,457,578 shares short
-1,011,926 shares (-7%) vs Oct 29, 2021
Published Nov 24, 2021.
Settlement Oct 29, 2021
14,469,504 shares short
+296,337 shares (+2.1%) vs Oct 15, 2021
Published Nov 9, 2021.
Settlement Oct 15, 2021
14,173,167 shares short
-291,829 shares (-2%) vs Sep 30, 2021
Published Oct 26, 2021.
Settlement Sep 30, 2021
14,464,996 shares short
+50,380 shares (+0.3%) vs Sep 15, 2021
Published Oct 11, 2021.
Settlement Sep 15, 2021
14,414,616 shares short
+1,449,732 shares (+11.2%) vs Aug 31, 2021
Published Sep 24, 2021.
Settlement Aug 31, 2021
12,964,884 shares short
-734,294 shares (-5.4%) vs Aug 13, 2021
Published Sep 9, 2021.
Settlement Aug 13, 2021
13,699,178 shares short
-870,516 shares (-6%) vs Jul 30, 2021
Published Aug 24, 2021.
Settlement Jul 30, 2021
14,569,694 shares short
-2,353,233 shares (-13.9%) vs Jul 15, 2021
Published Aug 10, 2021.
Settlement Jul 15, 2021
16,922,927 shares short
-4,474,534 shares (-20.9%) vs Jun 30, 2021
Published Jul 26, 2021.
Settlement Jun 30, 2021
21,397,461 shares short
+6,153,078 shares (+40.4%) vs Jun 15, 2021
Published Jul 9, 2021.
Settlement Jun 15, 2021
15,244,383 shares short
+671,658 shares (+4.6%) vs May 14, 2021
Published Jun 24, 2021.
Settlement May 14, 2021
14,572,725 shares short
+2,850,689 shares (+24.3%) vs Apr 30, 2021
Published May 25, 2021.
Settlement Apr 30, 2021
11,722,036 shares short
-1,353,576 shares (-10.4%) vs Apr 15, 2021
Published May 11, 2021.
Settlement Apr 15, 2021
13,075,612 shares short
+2,043,643 shares (+18.5%) vs Mar 31, 2021
Published Apr 26, 2021.
Settlement Mar 31, 2021
11,031,969 shares short
+3,740,316 shares (+51.3%) vs Mar 15, 2021
Published Apr 9, 2021.
Settlement Mar 15, 2021
7,291,653 shares short
-2,814,777 shares (-27.9%) vs Feb 26, 2021
Published Mar 24, 2021.
Settlement Feb 26, 2021
10,106,430 shares short
+7,686,385 shares (+317.6%) vs Jan 29, 2021
Published Mar 9, 2021.
Settlement Jan 29, 2021
2,420,045 shares short
+1,284,494 shares (+113.1%) vs Jan 15, 2021
Published Feb 9, 2021.
Settlement Jan 15, 2021
1,135,551 shares short
Published Jan 26, 2021.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Through Nov 14, 2026
Recorded amounts and dates, not confirmation of cash received.
| Ex-date | Event | Recorded detail |
|---|---|---|
| Nov 26, 2024 | Reverse split | 1 for 25Each 25 pre-split shares become 1 post-split share. |
| Jun 9, 2017 | Reverse split | 1 for 15Each 15 pre-split shares become 1 post-split share. |
Cash bars retain the event's recorded currency and share basis. The yield line divides recorded cash in the preceding 365 days, adjusted for intervening splits, by a verified raw close in the same currency. Special dividends are included. Future ex-dates are excluded from yield. A split changes share count, not investment value. For long shares, past entitlement depends on when you held them; short shares can create a dividend payment obligation.
Source: recorded cash-dividend and split events.
Link an account to see your stake, watchlist and past holdings.
We’ll show you if CTXR is in your portfolio and how much it contributes.
Sign in8 smart-money holders: institutions with a high Holder IQ
Red flags: 5
44 filers reported a long position in CTXR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
81%
of the 1.4M shares 13-F filers reported
Moves vs Q1 2026
5 added2 trimmed
1 new · 2 unchanged
Net shares held
+37.7%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | $130.3K · 215.5K shares | 215.5K | -12.4% |
| 2 | Vanguard Capital Management LLC | $119.4K · 197.4K shares | 197.4K | +17.7% |
| 3 | Miller Financial Services LLC | $78.6K · 130K shares | 130K | +828.6% |
| 4 | Citadel Advisors LLC | $75.5K · 124.9K shares | 124.9K | New |
| 5 | Jane Street Group, LLC | $74.3K · 122.8K shares | 122.8K | +445.4% |
| 6 | Vanguard Fiduciary Trust Co | $47K · 77.8K shares | 77.8K | Unchanged |
| 7 | BlackRock, Inc. | $42.2K · 69.9K shares | 69.9K | 0% |
| 8 | Northern Trust Corp | $37.9K · 62.7K shares | 62.7K | +42.7% |
| 9 | XTX Topco Ltd | $35.8K · 59.2K shares | 59.2K | +178% |
| 10 | Asset Advisory Group, Inc. | $35.7K · 59K shares | 59K | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of CTXR file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 14, 2026 | CVI Investments Inc13G · passive · amended | 9.9% |
How much of CTXR’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-14T15:48:49.009Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
Reading dated filing evidence…
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.
Read the balances behind the trades: SEC Forms 3, 4 and 5 state a reporting owner’s position, not just an amount bought or sold. These are dated filing observations, not current holdings or a trading signal.
Stock Option (Right to Purchase Common Stock) · Direct · Derivative units
Unavailable — most recently filed balance
Filed · report period Aug 8, 2025 · Form 4. Source: SEC filing 0001213900-25-090602. Quantities are reported units, not currency or market value.
Derivative units are recorded separately; no non-derivative share balance is inferred.
Underlying: Common Stock. Expiration: Oct 4, 2032. Exercise-price figure as filed: 31.2500; its currency is unavailable. No conversion into ordinary shares or dollars is made.
SEC identifiers: name as filed Mazur Leonard L · reporting-owner CIK 0001463414 · issuer CIK 0001506251
Comparable non-derivative observations are unavailable for this position. Read its separate as-filed evidence below.
· 22,000 derivative units in stored record · Direct
Report period Aug 8, 2025 · Form 4 · standalone holding line. SEC 0001213900-25-090602
Excluded from the comparison: Derivative units are recorded separately; no non-derivative share balance is inferred.
Link an account to see your stake, watchlist and past holdings. A reported balance adds context to a sale or purchase: an insider may still report a substantial position. This view does not calculate a percentage sold or a combined insider total. Different classes, indirect vehicles, derivatives and joint filers may overlap; changes can also reflect awards, gifts, exercises, splits or corrections. Neither a balance nor a change predicts your return.
Available filings through Nov 14, 2026; read Nov 14, 2026, 3:48 PM UTC. Latest 240 stored rows, up to 24 distinct reporting-owner positions. The bounded sample is truncated; older or additional positions may exist. 152 rows are outside the displayed position bound or have incompatible identities and are withheld. No holdings or account data about the reader enters this public evidence.
1Y price return -47%
Prices adjusted for splits; dividends excluded.
Nov 13, 2025–Nov 13, 2026. Returns are rebased to the first displayed observation. Prices use the latest stored close's share basis, linked backward through stored price returns. Marks use their recorded calendar dates, including non-trading days; their lanes do not imply a price or that an event caused a move.
Insiders: green purchases, red sales. Other lanes: 13F reporting period ends, stored earnings-calendar dates and flagged filings. Select a mark or open the dated list for its evidence.
Reported evidence, not a forecast
Above median holder quality (percentile 59.3 this quarter).
No stored transaction records were returned for this filing window. Last 180 days of filings: 0 purchases, 0 sales.
Late Form 4 filing